Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##FDA Approves New Cancer DrugThe FDA has approved a new drug for the treatment of a rare form of cancer. The drug has shown promising results in clinical trials and is expected to provide a new treatment option for patients with this type of cancer.##Biotech Company Reports Positive Phase 3 Trial ResultsA biotech company has announced positive results from a phase 3 clinical trial for its new drug. The drug has demonstrated significant efficacy in treating a certain condition, and the company plans to submit it for FDA approval soon.##Pharma Giant Acquires Small StartupA pharmaceutical giant has acquired a small startup company in a move to expand its portfolio of products. The acquisition will allow the company to access new technology and expertise in a specific area of research.##New Vaccine Shows Promising Results in Early StudiesA new vaccine being developed for a common infectious disease has shown promising results in early studies. The vaccine has demonstrated strong immune response and safety profile, raising hopes for its potential to prevent the disease.##Biopharma Company Receives Funding for Rare Disease ResearchA biopharma company focused on rare diseases has secured funding to support its research efforts. The funding will help the company advance its pipeline of treatments for rare genetic disorders, where there is a significant unmet medical need.